Cargando…
A Case of Advanced Multifocal Cholangiocarcinoma With Excellent Response to Pembrolizumab
The role of immune checkpoint inhibitors (ICIs) continues to receive more attention as evidence emerges of their efficacy and improved survival in patients with advanced biliary tract malignancies including cholangiocarcinoma (CCA). In line with this evidence, we describe the case of a 52-year-old m...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230845/ https://www.ncbi.nlm.nih.gov/pubmed/37266049 http://dx.doi.org/10.7759/cureus.38332 |